Skip to content

Erector Spinae Plane Block vs Quadratus Lumborum Block for Postoperative Pain Control in Patients Undergoing Laparoscopic nephrectomy: A double blinded, prospective, and randomized trial

Erector Spinae Plane Block vs Quadratus Lumborum Block for Postoperative Pain Control in Patients Undergoing Laparoscopic nephrectomy: A double blinded, prospective, and randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029207
Enrollment
Unknown
Registered
2020-01-18
Start date
2020-01-06
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic nephrectomy

Interventions

Group 2:Erector Spinae Plane Block

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. aged from 18 to 70 years, ASA I-II, BW 50-90kg; 2. scheduled for laparoscopic total or partial nephrectomy; 3. agreed to sign up consent of inform preoperatively;

Exclusion criteria

Exclusion criteria: 1. refused to join in the trial; 2. with chronic pain and is dependent on opoiod durgs or and kind of analgesic (more than 3 months); 3. with renal region pain; 4. With peripheral tissue invasion, lymph node metasis and need to receive renal artery embolism; 5. complicated with sever demntia, language barrier or communication disorder due to end-stage diseasse 6. allergic to ultrasonic coupling agent and local anesthetic drug; 7. not profitable for neural block due to local puncture site infection and coagulation disorder; 8. planned to admit in ICU; 9. not suitable for the trial by attending doctor or researcher.

Design outcomes

Primary

MeasureTime frame
total consumption of sufentanil in 48h;

Secondary

MeasureTime frame
Ultrasound imaging time;Injection time;Sensory block range;VAS score;first time to use PCA;times of supplementation of sufentanil;satisfaction of analgesic effect;Incidence of adverse reactions;Inflammatory response;

Countries

China

Contacts

Public ContactYu Zhuoying

Peking University Third Hospital

yingyiqing@126.com+86 13641002503

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026